Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Danaher Stock a Buy?


Investors in life sciences and diagnostics company Danaher (NYSE: DHR) have enjoyed a relatively good 2020 so far, with the stock rising 4.4% compared to a 11% decline in the S&P 500 index. In addition, it's the top-performing stock within its peer group. That said, the company's first-quarter sales came in lower than initial guidance, and CEO Tom Joyce believes its second-quarter core revenue growth will come "flat to down 10%."

In this context, is Danaher a stock to buy?

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
DHR
Share

Comments